Jack Ma, Sequoia China-backed biotech firm Brii Bio raises $155m in Series C round

Jack Ma, Sequoia China-backed biotech firm Brii Bio raises $155m in Series C round

Laboratory equipment. Photo: Pixabay

Brii Biosciences (Brii Bio), a multi-national innovative therapies developer with operations in both China and the US, has raised $155 million in a Series C round of financing ahead of a potential listing in Hong Kong.

The new financing was led by Invesco Developing Markets Fund, with significant additional funding from Singapore’s sovereign wealth fund GIC and another unspecified global investment management organisation, Brii Bio announced on Tuesday.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter